A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer

NCT05165264 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
600
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Bristol-Myers Squibb